|
ABX-002 Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- Autobahn Therapeutics, Inc.1
Indications
- Major Depressive Disorder1
- Depression1
Birmingham, Alabama1 trial
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Autobahn Site #131
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.